R-squared (Rituximab and Lenalidomide another immunotherapy treatment for Follicular Lymphoma
February 16 (edited)
Is rituximab used as a first-line treatment for follicular lymphoma?
Yes, rituximab (Rituxan) is commonly used as a first-line treatment for follicular lymphoma. It's often combined with chemotherapy drugs to create effective treatment regimens.
Common first-line combinations include
* R-Bendamustine: Rituximab with Show Full Answer
Is rituximab used as a first-line treatment for follicular lymphoma?
Yes, rituximab (Rituxan) is commonly used as a first-line treatment for follicular lymphoma. It's often combined with chemotherapy drugs to create effective treatment regimens.
Common first-line combinations include:
* R-Bendamustine: Rituximab with bendamustine
* R-CHOP: Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone
* R-CVP: Rituximab with cyclophosphamide, vincristine, and prednisone
Rituximab is a monoclonal antibody that works by targeting and removing B cells. It can be used alone or combined with chemotherapy to help control follicular lymphoma.
Another option for first-line treatment is obinutuzumab (Gazyva), which can be combined with bendamustine or chlorambucil. This might be considered if rituximab isn't the best fit for your situation.
Your oncology team will help determine which combination is right for you based on your specific case and overall health.
February 8
Join
Your Privacy Choices
